Beth mae “Clir” yn ei olygu?
Nid yw'r anifail yn cario'r treiglad. Ni fydd yn datblygu'r afiechyd ac ni fydd yn ei drosglwyddo.
Ci Dystroffinopathi Labradoodle Awstralia (DMD-AL)
Discover the Australian Labradoodle Dystrophinopathy (DMD-AL) DNA test, an essential tool for dog breeders and owners. This genetic test identifies the presence of mutations linked to DMD-AL, a condition affecting muscle strength and health in Australian Labradoodles. Early detection through DMD-AL testing can help prevent the onset of symptoms and guide responsible breeding practices. Ensure your furry friend’s well-being by opting for this crucial DNA test. By understanding your dog’s genetic profile, you can make informed decisions that promote a healthier, happier life. Trust the DMD-AL DNA test for a proactive approach to your Australian Labradoodle's health. Take action today to safeguard your pet's future!
Talfyriad: DMD-AL
Treiglad wedi'i ddadansoddi : DMD c.2668C>T
Etifeddiaeth: X-Linked Recessive
Acronym
DMD-AL
Amlder a arsylwyd
Difrifoldeb clinigol
Dosbarthiad clinigol
Clefydau Cyhyrol
Treiglad wedi'i ddadansoddi
DMD c.2668C>T
p.(R890*)
p.(R890*)
Modd etifeddiaeth
X-Linked Recessive
Alternate name:
Duchenne Muscular Dystrophy In Australian Labradoodle
Crynodeb prawf:
The Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition affecting Australian Labradoodles, characterized by a deficiency in dystrophin, a protein essential for muscle function. This DNA test helps identify carriers of the mutation responsible for the disease, allowing breeders to make informed decisions and reduce its prevalence. Early detection through genetic testing can lead to better management strategies and ensure healthier breeding practices. Responsible breeding can significantly improve the quality of life for affected dogs, promoting overall breed health. Owners and breeders are encouraged to utilize this test to support the wellbeing of future generations of Australian Labradoodles.
Ar gael o'r pecyn: Basic
Mae'r prawf DNA hwn wedi'i gynnwys gan ddechrau o'n pecyn Basic - ac mae hefyd yn rhan o'r pecynnau Basic, Standard, Advanced, Complete.
Gweld Pecynnau Prawf DNA →Dewiswch y pecyn sy'n gweddu orau i'ch strategaeth bridio neu iechyd eich anifeiliaid.
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL)
Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition that affects the muscle function of Australian Labradoodles. This disorder is caused by mutations in the dystrophin gene, which is essential for maintaining the integrity of muscle fibers. As a result, affected dogs may experience progressive muscle weakness and degeneration, leading to significant mobility issues over time.
Symptoms of DMD-AL
Dogs with DMD-AL often exhibit a range of symptoms that can vary in severity. Common signs include difficulty in walking, reluctance to engage in physical activities, and noticeable muscle wasting. As the disease progresses, owners may observe a decline in the dog’s overall stamina and strength, which can severely impact their quality of life.
Diagnosis of DMD-AL
Diagnosis of DMD-AL typically involves a combination of clinical evaluation and genetic testing. Veterinarians may conduct physical examinations to assess muscle strength and function. Additionally, DNA testing can confirm the presence of the specific mutations associated with DMD-AL, providing a definitive diagnosis.
Importance of DNA Testing
DNA testing for DMD-AL is crucial for breeders and dog owners alike. For breeders, it helps in making informed decisions to avoid producing affected puppies, thus contributing to the overall health of the breed. For owners, knowing whether their dog is a carrier or affected allows for better management of the condition and planning for future care needs.
Management of DMD-AL
Currently, there is no cure for DMD-AL, but management strategies can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and regular veterinary check-ups to monitor the progression of the disease. Owners should work closely with their veterinarians to develop a tailored management plan that addresses the specific needs of their dog.
Casgliad
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL) is essential for responsible dog ownership and breeding practices. DNA testing plays a vital role in identifying affected and carrier dogs, enabling proactive measures to promote the health and well-being of this beloved breed. Awareness and education about DMD-AL can significantly enhance the lives of both dogs and their owners.
Brid yn cael ei gydnabod ar gyfer y prawf: Dystroffinopathi Labradoodle Awstralia (DMD-AL)
- Labradoodle
🧬 Interpretation of genotypes DMD-AL
Genoteip
Statws
🟡 N/N
Heb fod yn gludwr - Dim Risg
❌ ♂ N/DMD-AL
Wedi'i Effeithio - Mewn Perygl
🟡 ♀ N/DMD-AL
Cludwr - Dim Risg
❌ DMD-AL/DMD-AL
Wedi'i Effeithio - Mewn Perygl
FAQ: deall y dehongliad
Ydy “Cludwr” yn ddifrifol?
Mae'r anifail yn gyffredinol iach ond gall drosglwyddo'r treiglad iddo epil.
Beth os yw anifail yn cael ei “Effeithio”?
Mae'n cario dau gopi treigledig. Disgwylir arwyddion clinigol yn dibynnu ar y clefyd. Ni ddylid ei fridio.
Pam mae gwahaniaethau rhwng gwryw / benyw?
Mae rhai afiechydon yn gysylltiedig â rhyw, felly mae eu mynegiant yn amrywio yn dibynnu ar y rhyw anifail.
Rhagfynegi Epil
N/N (heb-fod-yn-gludwr)
N/DMD-AL (Cludwr)
DMD-AL/DMD-AL (Wedi'i effeithio)
Cwestiynau Cyffredin Prawf DNA
Beth mae'r prawf DNA hwn yn ei ganfod?
This DNA test detects the mutation associated with Australian Labradoodle Dystrophinopathy (DMD) in order to identify clear, carrier, or at-risk animals.
Pam rhoi prawf ar anifail magu?
Mae profion DNA yn helpu bridwyr i gynllunio paru mwy diogel a lleihau'r risg o drosglwyddo'r mwtaniad i'r epil.
Beth yw modd etifeddiaeth y prawf hwn?
The inheritance mode reported for this test is X-Linked Recessive.
Pa dreiglad sy'n cael ei ddadansoddi yn y prawf hwn?
This test analyses the mutation DMD c.2668C>T.
A effeithir ar anifail cludo o reidrwydd?
Ddim o reidrwydd. Mae dehongliad yn dibynnu ar y patrwm etifeddiaeth a'r genoteip canlyniadol.
Cyfeiriadau
Shrader Stephanie M, Jung SeungWoo, Denney Thomas S, Smith Bruce F. Characterization of Australian Labradoodle dystrophinopathy. Neuromuscul Disord. 2018 Nov;28(11):927-937. doi: 10.1016/j.nmd.2018.08.008. Epub 2018 Aug 29.